Indeed, deletion of FABP4/aP2 leads to embryonic lethality [47,48] whilst diminished FABP4/aP4 gene expression has been shown to protect animals from multiple metabolic syndromes including obesity, insulin resistance, hepatosteatosis and atherosclerosis [49–52]. This evidence concerns the gene FABP4 and metabolic syndrome.